125 related articles for article (PubMed ID: 18811122)
1. Short chain aliphatic beta-nitro alcohols for corneoscleral cross-linking: corneal endothelial toxicity studies.
Paik DC; Wen Q; Braunstein RE; Trokel SL
J Refract Surg; 2008 Sep; 24(7):S741-7. PubMed ID: 18811122
[TBL] [Abstract][Full Text] [Related]
2. Initial studies using aliphatic beta-nitro alcohols for therapeutic corneal cross-linking.
Paik DC; Wen Q; Braunstein RE; Airiani S; Trokel SL
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1098-105. PubMed ID: 18836172
[TBL] [Abstract][Full Text] [Related]
3. Aliphatic beta-nitro alcohols for non-enzymatic collagen cross-linking of scleral tissue.
Paik DC; Wen Q; Airiani S; Braunstein RE; Trokel SL
Exp Eye Res; 2008 Sep; 87(3):279-85. PubMed ID: 18616942
[TBL] [Abstract][Full Text] [Related]
4. Aliphatic beta-nitroalcohols for therapeutic corneoscleral cross-linking: chemical mechanisms and higher order nitroalcohols.
Paik DC; Solomon MR; Wen Q; Turro NJ; Trokel SL
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):836-43. PubMed ID: 19797229
[TBL] [Abstract][Full Text] [Related]
5. Aliphatic β-nitroalcohols for therapeutic corneoscleral cross-linking: corneal permeability considerations.
Wen Q; Trokel SL; Kim M; Paik DC
Cornea; 2013 Feb; 32(2):179-84. PubMed ID: 22868628
[TBL] [Abstract][Full Text] [Related]
6. Aliphatic β-nitroalcohols for therapeutic corneoscleral cross-linking: chemical stability studies using 1H-NMR spectroscopy.
Li X; Li Y; Kim M; Trokel SL; Turro NJ; Paik DC
Photochem Photobiol; 2014; 90(2):338-43. PubMed ID: 23998198
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Toxicity/Fixation Balance for Corneal Cross-Linking With Sodium Hydroxymethylglycinate (SMG) and Riboflavin-UVA (CXL) in an Ex Vivo Rabbit Model Using Confocal Laser Scanning Fluorescence Microscopy.
Kim SY; Babar N; Munteanu EL; Takaoka A; Zyablitskaya M; Nagasaki T; Trokel SL; Paik DC
Cornea; 2016 Apr; 35(4):550-6. PubMed ID: 26807905
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use.
Yoeruek E; Spitzer MS; Saygili O; Tatar O; Biedermann T; Yoeruek E; Bartz-Schmidt KU; Szurman P
J Cataract Refract Surg; 2008 Dec; 34(12):2139-45. PubMed ID: 19027573
[TBL] [Abstract][Full Text] [Related]
9. Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus.
Goldich Y; Marcovich AL; Barkana Y; Avni I; Zadok D
Cornea; 2010 Apr; 29(4):409-11. PubMed ID: 20164744
[TBL] [Abstract][Full Text] [Related]
10. Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells.
Yoeruek E; Spitzer MS; Tatar O; Biedermann T; Grisanti S; Lüke M; Bartz-Schmidt KU; Szurman P
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1392-7. PubMed ID: 18385055
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of UVA Cytotoxicity for Human Endothelium in an Ex Vivo Corneal Cross-linking Experimental Setting.
Mooren P; Gobin L; Bostan N; Wouters K; Zakaria N; Mathysen DG; Koppen C
J Refract Surg; 2016 Jan; 32(1):41-6. PubMed ID: 26812713
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of blue-light scleral cross-linking.
Iseli HP; Spoerl E; Wiedemann P; Krueger RR; Seiler T
J Refract Surg; 2008 Sep; 24(7):S752-5. PubMed ID: 18811124
[TBL] [Abstract][Full Text] [Related]
13. The comparative safety of genipin versus UVA-riboflavin crosslinking of rabbit corneas.
Song W; Tang Y; Qiao J; Li H; Rong B; Yang S; Wu Y; Yan X
Mol Vis; 2017; 23():504-513. PubMed ID: 28761323
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility of trypan blue with human corneal cells.
van Dooren BT; Beekhuis WH; Pels E
Arch Ophthalmol; 2004 May; 122(5):736-42. PubMed ID: 15136322
[TBL] [Abstract][Full Text] [Related]
15. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro.
Wollensak G; Spörl E; Reber F; Pillunat L; Funk R
Ophthalmic Res; 2003; 35(6):324-8. PubMed ID: 14688422
[TBL] [Abstract][Full Text] [Related]
16. DNA cross-linking, double-strand breaks, and apoptosis in corneal endothelial cells after a single exposure to mitomycin C.
Roh DS; Cook AL; Rhee SS; Joshi A; Kowalski R; Dhaliwal DK; Funderburgh JL
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4837-43. PubMed ID: 18658091
[TBL] [Abstract][Full Text] [Related]
17. Safety of UVA-riboflavin cross-linking of the cornea.
Spoerl E; Mrochen M; Sliney D; Trokel S; Seiler T
Cornea; 2007 May; 26(4):385-9. PubMed ID: 17457183
[TBL] [Abstract][Full Text] [Related]
18. The effects of riboflavin and ultraviolet light on keratocytes cultured in vitro.
Covre JL; Cristovam PC; Loureiro RR; Hazarbassanov RM; Campos M; Sato ÉH; Gomes JÁ
Arq Bras Oftalmol; 2016; 79(3):180-5. PubMed ID: 27463630
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of accelerated corneal cross-linking versus conventional cross-linking: a comparative study on ex vivo-cultured limbal epithelial cells.
Shetty R; Matalia H; Nuijts R; Subramani M; Dhamodaran K; Pandian R; Jayadev C; Das D
Br J Ophthalmol; 2015 Feb; 99(2):272-80. PubMed ID: 25488945
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of riboflavin ultraviolet A corneal collagen cross-linking for Keratoconus in Italy: the Siena eye cross study.
Ashar JN; Vadavalli PK
Am J Ophthalmol; 2010 Oct; 150(4):588; author reply 588-9. PubMed ID: 20863921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
